Down syndrome gene-silencing strategy

Medical News Today, by Staff ~ October 24, 2013 The first evidence that the underlying genetic defect responsible for trisomy 21, also known as Down syndrome, can be suppressed in laboratory cultures of patient-derived stem cells was presented at the American Society of Human Genetics 2013 annual meeting in Boston. People with Down syndrome are